Craft

MPC Therapeutics

Total Funding

$1.6 M

MPC Therapeutics Summary

Company Summary

Overview
MPC Therapeutics is a company that develops drugs for mitochondria. Its therapeutic areas include mitochondrial carrier inhibitors, cancer immunotherapy, neurodegenerative diseases, metabolism modulation, etc.
Type
Private
Status
Active
Founded
2018
HQ
Geneva, CH | view all locations
Website
https://www.mpc-therapeutics.com/
Sectors

Key People

  • Raphael Martinou

    Raphael Martinou, CEO & Co-Founder

  • Augustin De Bettignies
  • Jean-Claude Martinou

    Jean-Claude Martinou, CSO

    • Mathias Wenes

      Mathias Wenes, Head of Immunotherapy

      LocationsView all

      1 location detected

      • Geneva, GE HQ

        Switzerland

        Chem. des Aulx 14

      Footer menu